A Spectral of Library Nanoparticle Contrast Agents for Spectral (Color) X-ray Imaging
A Spectral of Library Nanoparticle Contrast Agents for Spectral (Color) X-ray Imaging
批准号:
1309587
负责人:
Ryan Roeder
金额:
$38.0万
依托单位:
依托单位国家:
美国
项目类别:
Continuing Grant
财政年份:
2014
资助国家:
美国
项目状态:
已结题
起止时间:
2014-01-01 至 2017-12-31
中文摘要
该奖项由圣母大学材料研究部的生物材料计划颁发,旨在开发用于光谱(彩色)X射线成像的纳米颗粒X射线造影剂的谱库。该奖项由化学、生物工程、环境和运输系统分部的颗粒和多相工艺计划共同资助。能量敏感X射线探测器的最新进展使光谱计算机层析成像(CT)成为可能,因为它分解了不同材料的能量依赖的衰减分布。这项技术的商业化有望给X射线成像带来一场新的革命。然而,生理体液和软组织的光谱差异非常小,需要使用造影剂才能充分利用光谱CT。因此,需要进行基础材料研究来设计X射线造影剂的光谱库,以便充分利用光谱CT的能力。用于光谱CT的最合适的造影剂组合是未知的,甚至对于临床前研究也是不可用的。纳米颗粒的核心成分将被量身定做,以包括包裹在硅壳中的高原子序数材料;这些材料将根据已知的X射线吸收光谱(K-、L-吸收边)进行表征,以诊断不同的核心元素(Au、Bi、Ce、Gd和Hf)。纳米颗粒外壳将为表面功能化提供公共平台,选择分子配体来提供胶体稳定性、细胞相容性和/或靶向性。这种设计将产生一个通用的、但广泛适用的光谱库,该光谱库可以适应不同的需求,例如通过控制纳米颗粒的尺寸和表面功能化来实现被动和靶向传递。该项目的广泛影响包括:1)在研究人员实验室为本科生和高中生提供研究培训和指导;2)将这项研究纳入作为成像和治疗剂的靶向纳米颗粒的教学内容,以及3)为生物医学提供新的诊断工具。在上个世纪,X射线成像一直是非侵入性成像的主要手段,使医生能够诊断和治疗疾病和损伤。20世纪70年代,计算机断层扫描(CT)的出现使放射成像发生了革命性的变化,使三维成像成为可能。最近的发展使光谱(彩色)CT首次成为可能。这项技术将在X射线成像领域带来一场新的革命,但目前还缺乏合适的造影剂来充分利用光谱CT的能力。用于光谱CT的最合适的造影剂组合是未知的,甚至对于临床前研究也是不可用的。因此,需要对基础材料进行研究,设计一套作为X射线造影剂的谱库。光谱CT与本项目开发的纳米颗粒X射线造影剂光谱库相结合,将对生物医学产生重大影响。这项变革性的技术将使科学家和医生能够区分不同的材料、组织和液体,这在以前通过X射线成像是不可能的。因此,影响可能是深远的,影响用于疾病和损伤的研究、诊断和治疗的任何临床前和临床X射线成像。随着外展活动的开展,该项目将与圣母大学纳米科学与技术中心合作,为本科生提供研究培训。此外,高中生将接受这一研究项目的培训,以激发他们对STEM主题的兴趣。研究和教学的整合将通过将这个项目的研究方法和结果结合到一堂关于作为成像和治疗剂的定向纳米颗粒的讲座中来实现,该讲座将在生物材料的高级本科生和低级研究生课程中进行。
英文摘要
This award by the Biomaterials program in the Division of Materials Research to University of Notre Dame is to develop a spectral library of nanoparticle X-ray contrast agents for spectral (color) X-ray imaging. This award is cofunded by the Particulate and Multiphase Processes program in the Division of Chemical, Bioengineering, Environmental, and Transport Systems. Recent advances in energy-sensitive X-ray detectors have made spectral computed tomography (CT) feasible by unmixing the energy-dependent attenuation profile of different materials. The commercialization of this technology is expected to bring a new revolution to X-ray imaging. However, spectral differences in physiological fluids and soft tissues are sufficiently small that contrast agents are needed to take full advantage of spectral CT. Therefore, fundamental materials research is needed to design a spectral library of X-ray contrast agents in order to fully capitalize on the capabilities of spectral CT. The most appropriate combinations of contrast agents for spectral CT are not known and unavailable even for preclinical research. The core composition of the nanoparticles will be tailored to include materials with high atomic numbers encased in silica shells; these will be characterized with respect to known x-ray absorption spectra (K-, L-absorption edges) diagnostic for distinct core elements (Au, Bi, Ce, Gd and Hf). The nanoparticle shell will provide a common platform for surface functionalization with molecular ligands chosen to impart colloidal stability, cytocompatibility, and/or targeting. This design will lead to a common, but widely applicable, spectral library that is adaptable to different needs, such as passive vs. targeted delivery via control of the nanoparticle size and surface functionalization. Broader impacts of this project include: 1) providing research training and mentoring to undergraduate and high school students in the researchers laboratory; 2) incorporation of this research into instructional content on targeted nanoparticles as imaging and therapeutic agents, and 3) providing a new diagnostic tools for biomedicine.For the last century, X-ray imaging has been the primary means of non-invasive imaging enabling physicians to diagnose and treat disease and injury. Radiography was revolutionized in the 1970s by the advent of computed tomography (CT) which enabled three-dimensional imaging. Recent developments have made spectral (color) CT possible for the first time. This technology will lead to a new revolution in X-ray imaging, but suitable contrast agents are lacking to fully capitalize on the capabilities of spectral CT. The most appropriate combinations of contrast agents for spectral CT are not known and unavailable even for preclinical research. Therefore, fundamental materials research is needed to design a set of spectral library as X-ray contrast agents. Spectral CT, combined with a spectral library of nanoparticle X-ray contrast agents developed in this project, will have a significant impact in biomedicine. This transformational technology will enable scientists and physicians to differentiate various materials, tissues, and fluids, and this was not previously possible by X-ray imaging. Thus, the impact could be far-reaching, affecting any preclinical and clinical X-ray imaging for the study, diagnosis, and treatment of disease and injury. With resepect to outreach activities, this project will be providing research training to undergraduate students in collaboration with Notre Dame Center for Nano Science and Technology. Additionally, high school students will be trained in this reseach project to stimulate their interest in STEM topics. Integration of research and teaching will be accomplished by incorporating the research methods and results of this project into a lecture on targeted nanoparticles as imaging and therapeutic agents for an upper-level undergraduate and lower-level graduate course on Biomaterials.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
I-Corps: Noninvasive Monitoring of Implantable Devices via Methacrylate-Modified Nanoparticles (NanoMA)
-
批准号:2243707
-
项目类别:Standard Grant
-
资助金额:$5.0万
-
财政年份:2023
-
负责人:Ryan Roeder
-
依托单位:
Biological Materials Science Symposium; February 2009, San Francisco, CA
-
批准号:0855598
-
项目类别:Standard Grant
-
资助金额:$0.35万
-
财政年份:2009
-
负责人:Ryan Roeder
-
依托单位:
Biological Materials Science Symposium: New Orleans, LA; March 9-13, 2008
-
批准号:0757787
-
项目类别:Standard Grant
-
资助金额:$0.35万
-
财政年份:2007
-
负责人:Ryan Roeder
-
依托单位:
海外基金